New Delhi, June 11 (IANS). Union Minister of State for Health and Family Welfare and Chemicals and Fertilizers Anupriya Patel on Thursday said India is fast emerging as a global pharmaceutical superpower and is all set to lead the next wave of biopharmaceutical innovation.
Addressing the ASSOCHAM Pharma Summit & Awards 2026, he said the government is making continuous efforts to strengthen domestic manufacturing, promote innovation and develop a strong healthcare ecosystem, thereby ensuring long-term growth in the pharmaceutical and biotechnology sector.
“India is rapidly strengthening its position as a global pharmaceutical hub and is poised to lead the next generation of biopharmaceutical innovation,” he said.
Anupriya Patel said that the goal of self-reliant India in the pharmaceutical and biotechnology sector is not only an economic objective but also a strategic need of the country.
Referring to the Production Linked Incentive (PLI) schemes, he said that through these, there has been a significant increase in domestic production of Active Pharmaceutical Ingredients (APIs) and critical drugs, thereby reducing dependence on imports for key pharma raw materials.
Terming the biopharmaceutical sector as India’s next strategic frontier, the Union Minister said the recently announced Rs 10,000 crore ‘BioPharma Shakti Mission’ clearly reflects the government’s commitment towards innovation-based healthcare.
He said that this mission aims to develop at least 100 biologics by the year 2047 and make India a global hub for advanced treatments, innovative biologics and next generation health solutions. Additionally, this mission will also strengthen India’s global leadership role in the field of affordable generic medicines.
Anupriya Patel said, “The future of the pharma sector will belong to those countries that will innovate, enhance collaboration and develop solutions for the entire world. India is ready to lead this.”
He stressed the need for stronger collaboration between government, industry, educational institutions, startups, investors, regulatory bodies and health organizations, saying that this will further strengthen research capacity, manufacturing, supply chain and global quality standards.
On this occasion, Manoj Joshi, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, said that the Indian pharmaceutical industry is entering a new phase of growth on the strength of innovation, quality, regulatory excellence and global competitiveness.
At the same time, former Assocham President Anil K. Aggarwal said that the pharmaceutical sector is at a critical juncture where innovation, better regulatory regime and partnership-based collaboration can make India a global leader in advanced health solutions.
–IANS
dsc
